Dual Bronchodilation With Qva149 Reduces COPD Exacerbations: The Spark Study

被引：0
|
作者：
Wedzicha, J. A. [1 ]
Decramer, M. [2 ]
Ficker, J. [3 ]
Taylor, A. Fowler [4 ]
D'Andrea, P. [4 ]
Arrasate, C. [4 ]
Berhane, I. [4 ]
Chen, H. [4 ]
Banerji, D. [4 ]
机构：
[1] UCL, London, England
[2] Katolik Univ Leuven, Leuven, Belgium
[3] Klinikum Nuernberg, Nurnberg, Germany
[4] Novartis Pharmaceut, E Hanover, NJ USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2013年 / 187卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2428
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Once-daily QVA149 reduces exacerbations and improves health status in comparison with glycopyrronium and tiotropium in patients with severe-to-very severe COPD: The SPARK study
    Decramer, Marc
    Wedzicha, Jadwiga A.
    Ficker, Joachim H.
    FowlerTaylor, Angel
    D'Andrea, Peter
    Arrasate, Christie
    Chen, Hungta
    Banerji, Donald
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [22] Once-Daily QVA149 Reduces Exacerbations and Improves Health Status in Comparison With Glycopyrronium and Tiotropium in Patients With Severe-to-Very Severe COPD: The SPARK Study
    Wedzicha, Jadwiga
    Ficker, Joachim
    FowlerTaylor, Angel
    D'Andrea, Peter
    Arrasate, Christie
    Chen, Hungta
    Banerji, Donald
    CHEST, 2014, 145 (03)
  • [23] Impact of tiotropium on exacerbations versus glycopyrronium and QVA149
    Metzdorf, Norbert
    Hallmann, Christoph
    Disse, Bernd
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2015, 9 (06) : 675 - 676
  • [24] DUAL-BRONCHODILATION WITH ONCE-DAILY QVA149 IN PATIENTS WITH MODERATE-TO-SEVERE COPD: OVERVIEW OF THE IGNITE PROGRAM
    Price, D.
    Mezzi, K.
    Fedele, M. J.
    Chen, H.
    Banerji, D.
    THORAX, 2013, 68 : A183 - A184
  • [25] Dual bronchodilation with once-daily QVA149 improves dyspnea and health status and reduces symptoms and rescue medication use in patients with COPD: The IGNITE trials
    Banerji, Donald
    Alagappan, Vijay
    Green, Yulia
    Gallagher, Nicola
    FowlerTaylor, Angel
    D'Andrea, Peter
    Chen, Hungta
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [26] Safety And Tolerability Of Qva149, Glycopyrronium And Tiotropium In Patients With Severe To Very Severe COPD: The Spark Study
    Decramer, M.
    Wedzicha, J. A.
    Sandstrom, T.
    Niewoehner, D.
    Taylor, A. Fowler
    D'Andrea, P.
    Arrasate, C.
    Berhane, I.
    Chen, H.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [27] BENEFITS OF DUAL BRONCHODILATION WITH QVA149 ONCE DAILY VERSUS PLACEBO, INDACATEROL, NVA237 AND TIOTROPIUM IN PATIENTS WITH COPD: THE SHINE STUDY
    Frith, P.
    Thompson, P.
    Wark, P.
    Lindstrom, S.
    Bateman, E.
    RESPIROLOGY, 2013, 18 : 20 - 20
  • [28] Benefits of dual bronchodilation with QVA149 once daily versus placebo, indacaterol, NVA237 and tiotropium in patients with COPD: The SHINE study
    Bateman, Eric
    Ferguson, Gary T.
    Barnes, Neil
    Gallagher, Nicola
    Green, Yulia
    Horton, Rachael
    Henley, Michelle
    Banerji, Donald
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [29] Efficacy And Safety Of Qva149 Versus Glycopyrronium And Tiotropium In Severe To Very Severe COPD: The Spark Study
    Wedzicha, J. A.
    Decramer, M.
    Ficker, J.
    Niewoehner, D. E.
    Sandstrom, T.
    Taylor, A. Fowler
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [30] Efficacy And Safety Of Qva149 Versus Glycopyrronium And Tiotropium In A Subgroup Of Patients With Severe COPD: The Spark Study
    Wedzicha, J.
    D'Urzo, A. D.
    Decramer, M.
    Ficker, J. H.
    Sandstrom, T.
    Taylor, A. Fowler
    D'Andrea, P.
    Mezzi, K.
    Chen, H.
    Banerji, D.
    Fogel, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
12345